Comparison of proliferation and genomic instability responses to WRN silencing in hematopoietic HL60 and TK6 cells

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Ren, Xuefeng ^b   Lim, Sophia ^a   Ji, Zhiying ^a   Yuh, Jessica ^a   Peng, Vivian ^a   Smith, Martyn T ^a   Zhang, Luoping ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOM SYNDROME HELICASE; PROTEIN P53; RAD51 PROTEIN; RECQ HELICASE; RETINOBLASTOMA PROTEIN; SHORT HAIRPIN RNA; EXODEOXYRIBONUCLEASE; WRN PROTEIN, HUMAN;

ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HL 60; CHROMOSOME ABERRATION; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DEPLETION; DNA DAMAGE; FIBROBLAST; GEL ELECTROPHORESIS; GENE EXPRESSION; GENE SILENCING; GENOMIC INSTABILITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; PROTEIN PHOSPHORYLATION; SISTER CHROMATID EXCHANGE; WERNER SYNDROME; WILD TYPE; CELL CYCLE; CELL LINE; COMPARATIVE STUDY; GENETICS;

CELL CYCLE; CELL LINE; CELL PROLIFERATION; DNA DAMAGE; EXODEOXYRIBONUCLEASES; GENE SILENCING; GENOMIC INSTABILITY; HL-60 CELLS; HUMANS; RECQ HELICASES; TUMOR SUPPRESSOR PROTEIN P53; WERNER SYNDROME;

EID: 79251580717     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014546     Document Type: Article

References (71)

1. Oshima J (2000) The Werner syndrome protein: an update. Bioessays 22: 894-901.
2. Karow JK, Wu L, Hickson ID (2000) RecQ family helicases: roles in cancer and aging. Curr Opin Genet Dev 10: 32-38.
3. Bohr VA (2005) Deficient DNA repair in the human progeroid disorder, Werner syndrome. Mutat Res 577: 252-259.
4. Ouyang KJ, Woo LL, Ellis NA (2008) Homologous recombination and maintenance of genome integrity: Cancer and aging through the prism of human RecQ helicases. Mech Ageing Dev 129: 425-440.
5. Sidorova JM (2008) Roles of the Werner syndrome RecQ helicase in DNA replication. DNA Repair (Amst) 7: 1776-1786.
6. Rossi ML, Ghosh AK, Bohr VA (2010) Roles of Werner syndrome protein in protection of genome integrity. DNA Repair (Amst) 9: 331-344.
7. Goto M, Miller RW, Ishikawa Y, Sugano H (1996) Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 5: 239-246.
8. Furuichi Y (2001) Premature aging and predisposition to cancers caused by mutations in RecQ family helicases. Ann N Y Acad Sci 928: 121-131.
9. Khayat AS, Lobo Gatti L, Moura Lima E, de Assumpcao PP, Nascimento Motta FJ, et al. (2005) Polymorphisms of the TP53 codon 72 and WRN codon 1367 in individuals from Northern Brazil with gastric adenocarcinoma. Clin Exp Med 5: 161-168.
10. Wang Z, Xu Y, Tang J, Ma H, Qin J, et al. (2009) A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women. Breast Cancer Res Treat.
11. Nakayama R, Sato Y, Masutani M, Ogino H, Nakatani F, et al. (2008) Association of a missense single nucleotide polymorphism, Cys1367Arg of the WRN gene, with the risk of bone and soft tissue sarcomas in Japan. Cancer Sci 99: 333-339.
12. Ding SL, Yu JC, Chen ST, Hsu GC, Shen CY (2007) Genetic variation in the premature aging gene WRN: a case-control study on breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev 16: 263-269.
13. Agrelo R, Cheng WH, Setien F, Ropero S, Espada J, et al. (2006) Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci U S A 103: 8822-8827.
14. Chu WK, Hickson ID (2009) RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer.
15. Salk D, Bryant E, Hoehn H, Johnston P, Martin GM (1985) Growth characteristics of Werner syndrome cells in vitro. Adv Exp Med Biol 190: 305-311.
16. Poot M, Hoehn H, Runger TM, Martin GM (1992) Impaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines. Exp Cell Res 202: 267-273.
17. Szekely AM, Bleichert F, Numann A, Van Komen S, Manasanch E, et al. (2005) Werner protein protects nonproliferating cells from oxidative DNA damage. Mol Cell Biol 25: 10492-10506.
18. Opresko PL, Calvo JP, von Kobbe C (2007) Role for the Werner syndrome protein in the promotion of tumor cell growth. Mech Ageing Dev 128: 423-436.
19. Ren X, Lim S, Smith MT, Zhang L (2009) Werner syndrome protein, WRN, protects cells from DNA damage induced by the benzene metabolite hydroquinone. Toxicol Sci 107: 367-375.
20. Lebel M, Cardiff RD, Leder P (2001) Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicase. Cancer Res 61: 1816-1819.
21. Lebel M, Leder P (1998) A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc Natl Acad Sci U S A 95: 13097-13102.
22. Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, et al. (2000) Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 20: 3286-3291.
23. Chang S, Multani AS, Cabrera NG, Naylor ML, Laud P, et al. (2004) Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 36: 877-882.
24. Giacinti C, Giordano A (2006) RB and cell cycle progression. Oncogene 25: 5220-5227.
25. Brosh RM, Jr., Orren DK, Nehlin JO, Ravn PH, Kenny MK, et al. (1999) Functional and physical interaction between WRN helicase and human replication protein A. J Biol Chem 274: 18341-18350.
26. Franchitto A, Pichierri P (2004) Werner syndrome protein and the MRE11 complex are involved in a common pathway of replication fork recovery. Cell Cycle 3: 1331-1339.
27. Saintigny Y, Makienko K, Swanson C, Emond MJ, Monnat RJ, Jr. (2002) Homologous recombination resolution defect in werner syndrome. Mol Cell Biol 22: 6971-6978.
28. Chen L, Huang S, Lee L, Davalos A, Schiestl RH, et al. (2003) WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair. Aging Cell 2: 191-199.
29. Gowans ID, Lorimore SA, McIlrath JM, Wright EG (2005) Genotypedependent induction of transmissible chromosomal instability by gammaradiation and the benzene metabolite hydroquinone. Cancer Res 65: 3527-3530.
30. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
31. Pichierri P, Franchitto A, Mosesso P, Palitti F (2001) Werner's syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle. Mol Biol Cell 12: 2412-2421.
32. Chakraverty RK, Hickson ID (1999) Defending genome integrity during DNA replication: a proposed role for RecQ family helicases. Bioessays 21: 286-294.
33. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, et al. (2003) Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol 5: 675-679.
34. Klein HL (2008) The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair (Amst) 7: 686-693.
35. Henning W, Sturzbecher HW (2003) Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance. Toxicology 193: 91-109.
36. Gebhart E, Bauer R, Raub U, Schinzel M, Ruprecht KW, et al. (1988) Spontaneous and induced chromosomal instability in Werner syndrome. Hum Genet 80: 135-139.
37. Scappaticci S, Cerimele D, Fraccaro M (1982) Clonal structural chromosomal rearrangements in primary fibroblast cultures and in lymphocytes of patients with Werner's Syndrome. Hum Genet 62: 16-24.
38. Salk D, Au K, Hoehn H, Martin GM (1981) Cytogenetics of Werner's syndrome cultured skin fibroblasts: variegated translocation mosaicism. Cytogenet Cell Genet 30: 92-107.
39. Reliene R, Bishop AJ, Schiestl RH (2007) Involvement of homologous recombination in carcinogenesis. Adv Genet 58: 67-87.
40. Bishop AJ, Schiestl RH (2000) Homologous recombination as a mechanism for genome rearrangements: environmental and genetic effects. Hum Mol Genet 9: 2427-2334.
41. Roos WP, Nikolova T, Quiros S, Naumann SC, Kiedron O, et al. (2009) Brca2/ Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)- methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs. DNA Repair (Amst) 8: 72-86.
42. Sonoda E, Sasaki MS, Morrison C, Yamaguchi-Iwai Y, Takata M, et al. (1999) Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol Cell Biol 19: 5166-5169.
43. Shibuya H, Kato A, Kai N, Fujiwara S, Goto M (2005) A case of Werner syndrome with three primary lesions of malignant melanoma. J Dermatol 32: 737-744.
44. Salk D (1982) Werner's syndrome: a review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations. Hum Genet 62: 1-5.
45. Elledge SJ (1996) Cell cycle checkpoints: preventing an identity crisis. Science 274: 1664-1672.
46. Hallstrom TC, Nevins JR (2009) Balancing the decision of cell proliferation and cell fate. Cell Cycle 8: 532-535.
47. Giono LE, Manfredi JJ (2006) The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 209: 13-20.
48. Bartek J, Bartkova J, Lukas J (1996) The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 8: 805-814.
49. Blander G, Kipnis J, Leal JF, Yu CE, Schellenberg GD, et al. (1999) Physical and functional interaction between p53 and the Werner's syndrome protein. J Biol Chem 274: 29463-29469.
50. Sommers JA, Sharma S, Doherty KM, Karmakar P, Yang Q, et al. (2005) p53 modulates RPA-dependent and RPA-independent WRN helicase activity. Cancer Res 65: 1223-1233.
51. Constantinou A, Tarsounas M, Karow JK, Brosh RM, Bohr VA, et al. (2000) Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest. EMBO Rep 1: 80-84.
52. Brosh RM, Jr., Bohr VA (2002) Roles of the Werner syndrome protein in pathways required for maintenance of genome stability. Exp Gerontol 37: 491-506.
53. Otterlei M, Bruheim P, Ahn B, Bussen W, Karmakar P, et al. (2006) Werner syndrome protein participates in a complex with RAD51, RAD54, RAD54B and ATR in response to ICL-induced replication arrest. J Cell Sci 119: 5137-5146.
54. von Kobbe C, Karmakar P, Dawut L, Opresko P, Zeng X, et al. (2002) Colocalization, physical, and functional interaction between Werner and Bloom syndrome proteins. J Biol Chem 277: 22035-22044.
55. Yamamoto A, Taki T, Yagi H, Habu T, Yoshida K, et al. (1996) Cell cycledependent expression of the mouse Rad51 gene in proliferating cells. Mol Gen Genet 251: 1-12.
56. Vispe S, Cazaux C, Lesca C, Defais M (1998) Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res 26: 2859-2864.
57. Dudas A, Chovanec M (2004) DNA double-strand break repair by homologous recombination. Mutat Res 566: 131-167.
58. Ariyoshi K, Suzuki K, Goto M, Watanabe M, Kodama S (2007) Increased chromosome instability and accumulation of DNA double-strand breaks in Werner syndrome cells. J Radiat Res (Tokyo) 48: 219-231.
59. Lavoie J, Carter R, Drouin R, Lebel M (2005) Increased frequency of multiradial chromosome structures in mouse embryonic fibroblasts lacking functional Werner syndrome protein and poly(ADP-ribose) polymerase-1. Cancer Genet Cytogenet 156: 134-143.
60. Lu X, Lozano G, Donehower LA (2003) Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system. Mutat Res 522: 69-83.
61. Saintigny Y, Rouillard D, Chaput B, Soussi T, Lopez BS (1999) Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene 18: 3553-3563.
62. Bertrand P, Saintigny Y, Lopez BS (2004) p53's double life: transactivationindependent repression of homologous recombination. Trends Genet 20: 235-243.
63. Maacke H, Jost K, Opitz S, Miska S, Yuan Y, et al. (2000) DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene 19: 2791-2795.
64. Maacke H, Opitz S, Jost K, Hamdorf W, Henning W, et al. (2000) Overexpression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. Int J Cancer 88: 907-913.
65. Li B, Navarro S, Kasahara N, Comai L (2004) Identification and biochemical characterization of a Werner's syndrome protein complex with Ku70/80 and poly(ADP-ribose) polymerase-1. J Biol Chem 279: 13659-13667.
66. Li B, Comai L (2000) Functional interaction between Ku and the werner syndrome protein in DNA end processing. J Biol Chem 275: 28349-28352.
67. Kusumoto R, Dawut L, Marchetti C, Wan Lee J, Vindigni A, et al. (2008) Werner protein cooperates with the XRCC4-DNA ligase IV complex in endprocessing. Biochemistry 47: 7548-7556.
68. Shen M, Lan Q, Zhang L, Chanock S, Li G, et al. (2006) Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity. Carcinogenesis 27: 2083-2089.
69. Lan Q, Zhang L, Shen M, Jo WJ, Vermeulen R, et al. (2009) Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. Carcinogenesis 30: 50-58.
70. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175: 184-191.
71. Collins AR (2002) The comet assay. Principles, applications, and limitations. Methods Mol Biol 203: 163-177.